Stegent Equity Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,709
Closed -$326K 122
2026
Q1
$326K Buy
+2,709
New +$313K 0.28% 85

Other funds holding MRK

Stegent Equity Advisors's MRK Position: Q2 2026 in Review

Stegent Equity Advisors sold out of Merck (MRK) in Q2 2026, closing a stake of 2,709 shares — an estimated $326K sold.

Stegent Equity Advisors first reported a position in MRK in Q1 2026 and held it in 1 quarter. The position peaked at $326K in Q1 2026. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Stegent Equity Advisors reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Stegent Equity Advisors sold 2,709 Merck shares in Q2 2026, an estimated $326K.
  • Stegent Equity Advisors first reported a position in Merck in Q1 2026 and held it in 1 quarter.
  • Stegent Equity Advisors's Merck position peaked at $326K in Q1 2026.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Stegent Equity Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.